DFV-890 is under clinical development by Novartis and currently in Phase II for ...
OCT-461201 is under clinical development by Oxford Cannabinoid Technologies and ...
OCT-461201 is under clinical development by Oxford Cannabinoid Technologies and ...
Olanzapine ER is under clinical development by Teva Pharmaceutical Industries an...
MAS-825 is under clinical development by Novartis and currently in Phase II for ...
Olanzapine is under clinical development by Neurelis and currently in Phase I fo...
Omalizumab biosimilar is under clinical development by Teva Pharmaceutical Indus...
As Asda sets up a nationwide retail pharmacy in the UK and US grocer pharmacies ...
Using a specially designed 3D printed vacuum system, scientists have developed a...
Innovate UK has awarded funding to further optimise a unique and flexible floati...
Each of us individually is the accumulated product of thousands of generations t...
NEW YORK, NY–New groundbreaking images of one of the brain’s fastest-acting prot...
The Luxembourg Institute of Science and Technology (LIST) announces the launch o...
Poor diet continues to take a toll on American adults. It’s a major risk factor ...
ACM, the Association for Computing Machinery, today announced that Nivedita Aror...
Chronic wounds, which include diabetic ulcers, surgical wounds, pressure injurie...
